SE7803041L - Sett att framstella 16-metyl-9alfa-halogen-prednisolonoestrar och-etrar - Google Patents

Sett att framstella 16-metyl-9alfa-halogen-prednisolonoestrar och-etrar

Info

Publication number
SE7803041L
SE7803041L SE7803041A SE7803041A SE7803041L SE 7803041 L SE7803041 L SE 7803041L SE 7803041 A SE7803041 A SE 7803041A SE 7803041 A SE7803041 A SE 7803041A SE 7803041 L SE7803041 L SE 7803041L
Authority
SE
Sweden
Prior art keywords
prednisolonoesters
9alfa
ethers
halogen
methyl
Prior art date
Application number
SE7803041A
Other languages
Unknown language ( )
English (en)
Other versions
SE440656B (sv
Inventor
J E Villax
Original Assignee
Plurichemie Anstalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plurichemie Anstalt filed Critical Plurichemie Anstalt
Publication of SE7803041L publication Critical patent/SE7803041L/sv
Publication of SE440656B publication Critical patent/SE440656B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7803041A 1974-03-27 1978-03-16 Sett att framstella 16-metyl-9alfa-halogen-prednisolonestrar och -etrar SE440656B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PT6163674 1974-03-27
PT6163774 1974-03-27
PT6163675 1975-03-10

Publications (2)

Publication Number Publication Date
SE7803041L true SE7803041L (sv) 1978-03-16
SE440656B SE440656B (sv) 1985-08-12

Family

ID=27354092

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7803041A SE440656B (sv) 1974-03-27 1978-03-16 Sett att framstella 16-metyl-9alfa-halogen-prednisolonestrar och -etrar

Country Status (8)

Country Link
BE (1) BE827275A (sv)
CH (2) CH622811A5 (sv)
DK (1) DK153556C (sv)
FR (1) FR2274309A1 (sv)
GB (2) GB1510617A (sv)
IE (2) IE41138B1 (sv)
NZ (1) NZ177056A (sv)
SE (1) SE440656B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
IT1285770B1 (it) 1996-10-04 1998-06-18 Nicox Sa Composti corticoidei
CN102516348B (zh) * 2011-11-10 2013-11-13 中国科学院上海有机化学研究所 一种16s-甲基-20s-羟基孕甾化合物、合成方法及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070751A (en) * 1964-01-28 1967-06-01 Glaxo Lab Ltd 17-esters of 17-hydroxy-21-desoxy-steroids
GB1139505A (en) * 1965-06-23 1969-01-08 Glaxo Lab Ltd A process for the production of 17-‡-monoesters of 17-‡-hydroxy-20-keto-steroids
CH481085A (de) * 1965-08-30 1969-11-15 Scherico Ltd Verfahren zur Herstellung von 11B-Hydroxy-17 -alkanoyloxysteroiden der Pregnanreihe
US3383394A (en) * 1965-08-30 1968-05-14 Schering Corp Novel 17-acylating process and products thereof
BE788355A (fr) * 1971-09-07 1973-03-05 Merck Patent Gmbh Esters de 9 alpha-fluoro-16-methylene-prednisolone

Also Published As

Publication number Publication date
FR2274309A1 (fr) 1976-01-09
IE41137B1 (en) 1979-10-24
NZ177056A (en) 1978-09-20
DK153556B (da) 1988-07-25
DK129575A (sv) 1975-09-28
CH622811A5 (sv) 1981-04-30
BE827275A (fr) 1975-07-16
IE41137L (en) 1975-09-27
FR2274309B1 (sv) 1978-11-24
GB1511820A (en) 1978-05-24
IE41138B1 (en) 1979-10-24
SE440656B (sv) 1985-08-12
CH625254A5 (sv) 1981-09-15
GB1510617A (en) 1978-05-10
DK153556C (da) 1988-12-05

Similar Documents

Publication Publication Date Title
IT1047093B (it) Uretandossazolidine e procedimento per produrle
SE411766B (sv) Herdbar komposition och sett att framstella densamma
SE7514514L (sv) D-homo-20-ketopregnaner och sett att framstella desamma
SE7506743L (sv) Sett att framstella bispidin- och bispidonderivat
BG23208A3 (bg) Метод за получаване на низши алкил-третични-бутил етери
SE404804B (sv) Sett att framstella 18-metyl-19-nor-20-ketopregnaner
DK269175A (da) Fremgangsmade til fremstilling af d-phenylglycinamid og l-phenylglycin
SE430608B (sv) Forfarande for framstellning av etrar av polysackarider
SE7508544L (sv) Bensimidazol-derivat och sett att framstella desamma.
SE7511438L (sv) 7-hydroxi-ostradioler och sett att framstella desamma
SE7511618L (sv) 1alfa-hydroxisteroider och sett att framstella densammma
SE7511931L (sv) Penicilliner och forfarande for framstellning derav
IT1054363B (it) Procedimento per produrre l cisteina e l cistina
SE7513302L (sv) Framstellning av etrar
IT1029437B (it) Perfluorda-chiltioglicoli e procedimento per produrli
SE7803041L (sv) Sett att framstella 16-metyl-9alfa-halogen-prednisolonoestrar och-etrar
SE7508561L (sv) Sett att framstella alfa-azidobensylpenicillin
SE7509569L (sv) Framstellning av etrar
AT336773B (de) Kunstliches bein
JPS5172494A (ja) Gasukenchiteepu
SE7511825L (sv) Vermevexlartub och sett att framstella denna
SE7510083L (sv) 1-tiadiazolyl-6-acyloxitetrahydropyrimidinoner och sett att framstella dessa
IT1037092B (it) Tetraidopiranil eteri di estrugeni
SE414180B (sv) Sett att framstella bufadienolid- och bufatrienolidetrat
FR2290416A1 (fr) Preparation de triamino-benzenes

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7803041-8

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7803041-8

Format of ref document f/p: F